Detailed answers about ADVANCED CLINICAL RESEARCH SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was ADVANCED CLINICAL RESEARCH SERVICES LIMITED founded?
ADVANCED CLINICAL RESEARCH SERVICES LIMITED was officially incorporated on 3 May 2018 and is registered under company number 11344817. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ADVANCED CLINICAL RESEARCH SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ADVANCED CLINICAL RESEARCH SERVICES LIMITED?
ADVANCED CLINICAL RESEARCH SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ADVANCED CLINICAL RESEARCH SERVICES LIMITED do?
ADVANCED CLINICAL RESEARCH SERVICES LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is ADVANCED CLINICAL RESEARCH SERVICES LIMITED's registered address?
The registered office address of ADVANCED CLINICAL RESEARCH SERVICES LIMITED is BUILDING 2, GUILDFORD BUSINESS PARK, GUILDFORD, ENGLAND, GU2 8XG. This is the official address filed with Companies House for legal and statutory correspondence.
Is ADVANCED CLINICAL RESEARCH SERVICES LIMITED financially stable?
The most recent accounts for ADVANCED CLINICAL RESEARCH SERVICES LIMITED were made up to 31 December 2024, filed as SMALL. Next accounts are due by 30 September 2026.